Harvard Bioscience (HBIO) News
NASDAQ: HBIOIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
8.66-0.02 (-0.23%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
HBIO news summary
We found 6 recent headlines mentioning Harvard Bioscience (HBIO): 0 in the past week and 6 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, HBIO is down 0.23% at $8.66. The most recent story, "Harvard Bioscience Consensus Price Target Raised 26.83% to $13.26", was published by Nasdaq on Nov 12, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Harvard Bioscience headlines
- Harvard Bioscience Consensus Price Target Raised 26.83% to $13.26The average one-year price target for Harvard Bioscience (NASDAQCM:HBIO) (DB:HBI0) has been revised to $13.26 / share. This is an increase of 26.83% from the prior estimate of $10.46 dated November…Nasdaq
- Harvard Bioscience (HBIO) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Harvard Bioscience Announces Third Quarter 2026 Financial ResultsHarvard Bioscience Announces Third Quarter 2026 Financial ResultsGlobeNewswire
- Harvard Bioscience Consensus Price Target Increased by 36.67% to $10.46The average one-year price target for Harvard Bioscience (NASDAQCM:HBIO) (DB:HBI0) has been revised to $10.46 / share. This is an increase of 36.67% from the prior estimate of $7.65 dated October 30,…Nasdaq
- Harvard Bioscience to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services ForumHBIO - Canaccord Conference ReleaseGlobeNewswire
- Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ETHarvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ETGlobeNewswire